Physician profile
Uma Khanna
NPI 1255342432
$1,090.91
in general payments reported to CMS, 2019-2025
13 companies · $94.30 in 2025
The $94.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $57.79 · 2021: $128 · 2022: $206 · 2023: $54.62 · 2024: $234 · 2025: $94.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $328.64 | 2019-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $216.70 | 2019-2025 | Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $127.59 | 2022 | |
| Janssen Pharmaceuticals, INC | $113.29 | 2019 | |
| Novo Nordisk INC | $66.00 | 2022 | |
| Lilly USA, LLC | $47.93 | 2020-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.97 | 2024 | Jardiance, Synjardy, Tradjenta |
| Mylan Specialty L.P. | $38.04 | 2023 | Yupelri |
| Amarin Pharma, INC. | $31.99 | 2020-2021 | |
| Pfizer INC. | $29.95 | 2019 | |
| Vivus LLC | $20.90 | 2021 | |
| Merck Sharp & Dohme LLC | $12.89 | 2019 | |
| Allergan, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Khanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.